Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $100000.0.

  • Q32 Bio's Depreciation & Amortization (CF) changed 0.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $419000.0, marking a year-over-year decrease of 647.32%. This contributed to the annual value of $500000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Q32 Bio reported Depreciation & Amortization (CF) of $100000.0 as of Q3 2025, which was down 0.0% from $100000.0 recorded in Q2 2025.
  • Over the past 5 years, Q32 Bio's Depreciation & Amortization (CF) peaked at $2.1 million during Q1 2021, and registered a low of $100000.0 during Q3 2023.
  • In the last 5 years, Q32 Bio's Depreciation & Amortization (CF) had a median value of $127000.0 in 2023 and averaged $575894.7.
  • In the last 5 years, Q32 Bio's Depreciation & Amortization (CF) soared by 1012.06% in 2021 and then crashed by 8571.43% in 2022.
  • Over the past 5 years, Q32 Bio's Depreciation & Amortization (CF) (Quarter) stood at $2.1 million in 2021, then plummeted by 85.71% to $300000.0 in 2022, then tumbled by 58.33% to $125000.0 in 2023, then dropped by 20.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Its last three reported values are $100000.0 in Q3 2025, $100000.0 for Q2 2025, and $119000.0 during Q1 2025.